FPS
CYTK icon

Fieldpoint Private Securities’s Cytokinetics CYTK Stock Holding History

Fieldpoint Private Securities’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35
Closed -$1K – 1535
2022
Q1 		$1K Buy
35
+5
+17% +$178 ﹤0.01% 1555
2021
Q4 		$1K Buy
+30
New +$1.16K ﹤0.01% 1548

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Fieldpoint Private Securities's CYTK Position: Q2 2022 in Review

Fieldpoint Private Securities sold out of Cytokinetics (CYTK) in Q2 2022, closing a stake of 35 shares — an estimated $1K sold.

Fieldpoint Private Securities first reported a position in CYTK in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 262 funds tracked by Wall St. Rank hold CYTK as of Q2 2022.

  • Fieldpoint Private Securities reported no remaining Cytokinetics position as of Q2 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 35 Cytokinetics shares in Q2 2022, an estimated $1K.
  • Fieldpoint Private Securities first reported a position in Cytokinetics in Q4 2021 and held it in 2 quarters.
  • Fieldpoint Private Securities's Cytokinetics position peaked at $1K in Q1 2022.
  • 262 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.